Amicus Therapeutics (FOLD) Tops Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops more than 4% on talks aimed at ending US-Iran war
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mail
Get Alerts FOLD Hot Sheet
Price: $14.49 --0%
Financial Fact:
Benefit from income taxes: 253K
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Benefit from income taxes: 253K
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Amicus Therapeutics (NASDAQ: FOLD) reported Q4 EPS of $0.09, $0.08 better than the analyst estimate of $0.01.
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic PBC: adjusted operating income increased for the three months ended September 30, 2026 to $2.5 billion
- Alphabet to raise EUR 6B from euro bond sale - Bloomberg
- Regeneron Pharma (REGN) PT Raised to $980 at Cantor Fitzgerald
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
